Internal Medicine, Nephrology · Wichita Falls, TX
NPI
1528129871
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1517 10th St
Wichita Falls, TX, 76301
Phone (940) 322-1411
Groups this clinician bills Medicare through
Medicare paid, 2024
$619K
35,500 services
Medicare patients, 2024
1,578
Average age 75
Drug cost, 2024
$1.4M
4,894 prescriptions
Company payments, 2025
$495
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashvinkumar N Patel was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 28,601 times for 21 patients. In total Ashvinkumar N Patel billed 35,500 services in 19 codes, and Medicare paid $619K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 28,601 | 21 | $2.22 | $64K |
| 99213 Office E&M - Established | Office | 2,637 | 1,169 | $53.60 | $141K |
| 99232 Hospital E&M - Subsequent | Facility | 1,710 | 379 | $51.20 | $88K |
| 90960 ESRD Related Services (not dialysis) | Office | 475 | 67 | $225.29 | $107K |
| 90961 ESRD Related Services (not dialysis) | Office | 408 | 93 | $185.37 | $76K |
| 99221 Hospital E&M - Initial | Facility | 382 | 269 | $52.49 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 328 | 100 | $76.82 | $25K |
| 90966 ESRD Related Services (not dialysis) | Office | 243 | 29 | $184.77 | $45K |
| 99204 Office E&M - New | Office | 236 | 236 | $104.68 | $25K |
| 96372 Injection Administration | Office | 147 | 21 | $9.28 | $1,364 |
| 99222 Hospital E&M - Initial | Facility | 142 | 142 | $82.17 | $12K |
| 90962 ESRD Related Services (not dialysis) | Office | 64 | 37 | $130.11 | $8,327 |
| 99214 Office E&M - Established | Office | 62 | 59 | $74.66 | $4,629 |
| 99212 Office E&M - Established | Office | 35 | 24 | $34.93 | $1,223 |
| 99231 Hospital E&M - Subsequent | Facility | 15 | 15 | $32.53 | $488 |
By year: 2022 $872K for 58,189 services; 2023 $795K for 51,724 services; 2024 $619K for 35,500 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashvinkumar N Patel prescribed most often to Medicare patients was Allopurinol, with 434 prescriptions and refills. In total Ashvinkumar N Patel wrote 4,894 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Allopurinol Generic | 434 | 1,088 | 133 | $4,426 |
| Velphoro Sucroferric Oxyhydroxide | 387 | 452 | 77 | $1.1M |
| Amlodipine Besylate Generic | 375 | 857 | 116 | $2,306 |
| Clonidine Hcl Generic | 232 | 478 | 73 | $2,371 |
| Sevelamer Carbonate Generic | 207 | 255 | 48 | $35K |
| Hydralazine Hcl Generic | 192 | 445 | 61 | $2,721 |
| Furosemide Generic | 160 | 395 | 63 | $829 |
| Bumetanide Generic | 116 | 248 | 36 | $3,521 |
| Potassium Chloride Generic | 107 | 239 | 43 | $2,311 |
| Losartan Potassium Generic | 106 | 288 | 39 | $1,167 |
| Lisinopril Generic | 101 | 219 | 28 | $602 |
| Olmesartan Medoxomil Generic | 95 | 231 | 32 | $2,554 |
| Telmisartan Generic | 91 | 229 | 28 | $2,432 |
| Calcium Acetate Generic | 89 | 121 | 24 | $7,406 |
| Nifedipine Er Nifedipine | 85 | 195 | 29 | $2,118 |
Brand drugs: - claims; generic drugs: 4,309 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashvinkumar N Patel $495 ($495 in general payments such as food, travel and fees) from 4 companies. The largest payer was Fresenius USA Marketing, Inc. with $317.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.